Meeting
2013 ASCO Annual Meeting
Open-label, phase IIIb, multicenter, expanded access study of everolimus in patients with advanced neuroendocrine tumors (NET).
Authors
Oliver Edgar Bechter
Universitz Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium
Oliver Edgar Bechter , Nicole Unger , Ivan Borbath , Sergio Ricci , Tsann-Long Hwang , Young Suk Park , Jiri Tomasek , Hussein Raef , Sudsawat Laohavinij , Lisa JeanLouis , Ashok Panneerselvam , Stephen Saletan , Sotirios G. Stergiopoulos , Marianne E. Pavel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Neuroendocrine/Carcinoid
Clinical Trial Registration Number
EudraCT Number: 2010-023032-17
Citation
J Clin Oncol 31, 2013 (suppl; abstr 4138)
DOI
10.1200/jco.2013.31.15_suppl.4138
Abstract #
4138
Poster Bd #
30H
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Study of cabozantinib in second line under real-life setting in patients with advanced renal cell carcinoma (aRCC): Study design of a French retrospective, multicenter study (OCTOPUS).
First Author: Antoine Thiery-Vuillemin
Poster
2021 ASCO Annual Meeting
First long-term results on efficacy and safety of long-acting pasireotide in combination with everolimus in patients with advanced carcinoids (NET) of the lung/thymus: Phase II LUNA trial.
First Author: Eric Baudin
Poster
2021 ASCO Annual Meeting
Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.
First Author: Wei Wei
Poster
2020 ASCO Virtual Scientific Program
Safety of 177Lu‑DOTATATE in patients with advanced neuroendocrine tumors: Data from a U.S. expanded access program.
First Author: Martin S. Auerbach